Skip to content

Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures

Prosthesis Versus Osteosynthesis in Treatment of Intra-articular Fractures of Proximal Tibia: A Randomized, Controlled, Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03172715
Acronym
POSITIF
Enrollment
98
Registered
2017-06-01
Start date
2018-01-09
Completion date
2029-06-30
Last updated
2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tibial Fractures

Keywords

Open reduction internal fixation, Arthroplasty, Surgery, Randomized controlled trial

Brief summary

The aim of this study is to compare knee function and pain one year after treatment of intra-articular proximal tibia fracture using either osteosynthesis with a locking plate (ORIF) or primary total knee replacement (TKR) in patients over 65 years of age.

Detailed description

Intra-articular proximal tibial fractures are relatively common in the elderly. They constitute 8% of all fractures in patients over 65 years. Open reduction and internal fixation (ORIF) is the golden standard treatment for these fractures. The treatment with ORIF is associated with significant co-morbidity due to complicating concomitant factors, such as osteoporosis, poor co-operation, infection and inadequate stability of osteosynthesis. A high failure rate (30-79 %) of fixation of tibia plateau fractures in elderly people has been reported. Most of these fractures occur in elderly persons who are at risk to lose their ability to walk independently, because of partial immobilization is required initially and full weight bearing is not allowed during 6 to 8 weeks after the operation. The risk of post-traumatic osteoarthritis has been reported to be 5.3-times higher than in the normal population even if adequate stability is achieved and other conditions normalized for fracture healing. It has also been reported that total knee replacement (TKR) performed for post-traumatic arthritis after tibial plateau fracture lead to worse outcome compared with TKR due to primary osteoarthritis. In addition, previous operations increase the risk of complications after TKR. The complication rate in secondary TKR has been reported to be over 18 %. The available data regarding TKR as a primary treatment option for proximal tibial plateau fracture suggest that fast mobilization and return to normal daily activities may be achieved. These data also suggest a low rate of complications. There are no randomized controlled trials comparing the outcomes of the traditional treatment option (open reduction- internal fixation, ORIF) and TKR as primary treatment of these fractures. In this study investigators compare the outcomes of locking plate osteosynthesis and total knee arthroplasty according to Oxford knee score, pain, ability to walk, or quality of life one year after randomization in 98 patients aged over 65 years.

Interventions

PROCEDURELocking plate

Osteosynthesis

PROCEDURETKR

Total knee arthroplasty

Sponsors

Tampere University Hospital
CollaboratorOTHER
Coxa, Hospital for Joint Replacement
CollaboratorOTHER
Oulu University Hospital
CollaboratorOTHER
Turku University Hospital
CollaboratorOTHER_GOV
Kuopio University Hospital
CollaboratorOTHER
Seinajoki Central Hospital
CollaboratorOTHER
Paijat-Hame Hospital District
CollaboratorOTHER
Central Finland Hospital District
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute intra-articular proximal tibia fracture with impression of the joint cartilage (Schatzker grades II to VI) * Impression of tibial plateau min 2 mm * Intact patellar tendon * The patient accepts both treatment options (osteosynthesis and arthroplasty)

Exclusion criteria

* Not voluntary * Previous arthroplasty of the knee * Previous fracture affecting the knee joint * Inability to co-operate * Not independent (institutionalized living before fracture) * Severe osteoarthritis (Kellgren-Lawrence grade 4) * Open fracture (Gustilo grade 2 or over) * Progressive metastatic malign disease * Multiple fractures requiring operative treatment * Severe soft tissue injury around the knee (Tscherne classification grade 3) * Avulsion fracture of the patellar tendon or concomitant patellar tendon tear * Inability to walk before fracture * Severe medical comorbidities * Body Mass Index over 40 * Unacceptably high risk of surgery due to severe medical comorbidities * Significant arterial or nerve trauma * Severe substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Knee function12 monthsOxford knee score 12 months after randomisation

Secondary

MeasureTime frameDescription
Change in painBaseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsNumeric rating scale (rest, night, exercise)
Change in physical performance6 weeks (TKR only), 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsShort Physical Performance Battery (SPPB)
Change in quality of lifeBaseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsShort form-36 (SF-36)
ReoperationsUp to 10 years following randomisationNeed for revision surgery
SatisfactionBaseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsSatisfaction with knee (Numeric rating scale, range 0 to 10)
Change in knee functionBaseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsChange in Oxford knee score

Other

MeasureTime frameDescription
Medical and social services (quantity)Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsUse of medical and social services (quantity)
Medical and social services (costs)Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsCosts of medical and social services used
ComplicationsBaseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsAny complication following injury or treatment
Pain medicationBaseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 5 years, 10 yearsPain medication used (pills per day)

Countries

Finland

Contacts

Primary ContactJuha Paloneva, MD, PhD
juha.paloneva@ksshp.fi+358 14 2693119

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026